FDA Approves Drug for Treatment of Nocturnal PolyuriaNoctiva is the first agent approved to temporarily decrease urine production in adults with nocturia from various causes.
Uro Pipeline: Bladder Ca drug-device combination begins second phase Ib trialA bladder cancer drug-device combination, a localized prostate cancer agent, and a new surgical robot are among other treatments in the pipeline discussed in this round-up.
Urine tests predict early onset NECResearchers have found that simple tests for levels of alanine and histidine in newborns’ urine can predict abnormal levels of gut bacteria before the onset of necrotizing enterocolitis (NEC).